PrEP's promise to change the urse of HIV has succeed — but only for whe gay men

gay prep pills

Oral HIV preventn pills, like Tvada and Dvy, have achieved populary — among whe gay and bisexual men. But what about Apretu jectable PrEP?

Contents:

PREP FOR GAY MEN 101: EVERYTHG GAY MEN NEED TO KNOW ABOUT TAKG HIV PREVENTN MEDITN!

* gay prep pills *

There is scientific evince that the “2-1-1” schle provis effective protectn for gay and bisexual men* when havg anal sex whout a ndom.

Some health partments the Uned Stat and some health anizatns Europe and Canada are offerg guidance for “on-mand” PrEP as an alternative to daily PrEP for gay and bisexual men at risk for HIV. * The term “gay and bisexual men” is ed to scribe men who intify as gay or bisexual, as well as men who have sex wh men who do not intify as gay or bisexual. PrEP n be prcribed as Tvada or Dvy for gay and bisexual men, heterosexual men and women, for trans+ and genr nonnformg folks.

It was a perd of uncertaty as healthre provirs stggled to make sense of the disease that was ravagg the gay muny. The gay muny, which was already spised and margalized for the way s members chose to live and love, was an easy victim. The disease was at that pot lled GIRD (Gay-Related Immunoficiency) and everyone assumed was a punishment flicted upon gay people for livg like generat.

PREP'S PROMISE TO CHANGE THE URSE OF HIV HAS SUCCEED — BUT ONLY FOR WHE GAY MEN

Use of PrEP, or Tvada, an HIV preventn pill, jumped om 6 percent 2014 to 35 percent 2017. Awarens is high among gay and bisexual men. * gay prep pills *

Even healthre profsnals discrimated agast gay men fected wh the vis, and only a handful of them took those sufferg om and sought to, at the very least, make their last days fortable.

Nelson lamented the gulf between PrEP’s imprsive performance major studi and s morate real-world the bright si, PrEP, which is short for pre-exposure prophylaxis and volv takg eher oral or jectable prcriptn antiretroviral meditns advance of potential HIV exposure, has ed achieved substantial populary — but only among whe gay and bisexual men, who have long seen a droppg HIV equy persists spe the efforts of a natnwi public-health army and untls lns of dollars spent promotg and facilatg PrEP e among Black and Lato gay and bi men.

Acrdg to the Centers for Disease Control and Preventn, gay and bi men acunt for 70% of new s of the vis. Consequently, even after clil trials found jectable PrEP was dramatilly superr to oral PrEP at preventg HIV on a public health level, pecially among Black gay men, Apretu’s potential will likely rema untapped for the foreeable future. When eher dg is taken daily, this lowers the risk of HIV by at least 99% among gay and bi men and transgenr women, acrdg to multiple studi.

PREP E JUMPS TO 35 PERCENT AMONG GAY AND BI MEN AT RISK OF HIV

Approximately 814, 000 gay and bi men the U.

Between 2017 and 2022, the number of people g PrEP, who have always overwhelmgly been gay and bi men, at any pot durg each given year creased om 155, 000 to 382, 000. Of the CDC’s timate of 21, 900 new HIV s 2019 (the most recent year for which the agency has produced a transmissn timate) the three largt racial groups among gay and bi men, a rpective 23%, 41% and 36% were wh, Blacks and Latos. Apretu’s superr efficy was driven by the fact that participants adhered better to the jectn schle than to the daily pill Hyman Stt, an HIV preventn expert at the San Francis Department of Public Health, reported at the Seattle nference that of the 844 Black Amerin participants the trial, those randomized to receive the jectable dg had a 72% lower HIV rate than those who got analysis suggts that if 10, 000 siar Black gay and bi men and trans women were followed for one year, approximately 50 would ntract HIV if given Apretu, while 200 would tt posive if provid soberg fdgs about Tvada’s shortgs are keepg wh prev studi fdg relatively low rat of adherence to the daily PrEP regimen among Black gay men.

*BEAR-MAGAZINE.COM* GAY PREP PILLS

What is PrEP? - Gay Health Task Force .

TOP